Brokers Issue Forecasts for CDTX Q2 Earnings
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Free Report) – Analysts at HC Wainwright issued their Q2 2025 earnings estimates for Cidara Therapeutics in a research report issued to clients and investors on Wednesday, June 18th. HC Wainwright analyst S. Nik expects that the biotechnology company will earn ($2.11) per share for the quarter. HC Wainwright has […]
